scispace - formally typeset
C

Cheng Li

Researcher at Peking University

Publications -  238
Citations -  49764

Cheng Li is an academic researcher from Peking University. The author has contributed to research in topics: Gene & Medicine. The author has an hindex of 63, co-authored 200 publications receiving 42539 citations. Previous affiliations of Cheng Li include University of California, Los Angeles & Tongji University.

Papers
More filters
Journal ArticleDOI

The hierarchical folding dynamics of topologically associating domains are closely related to transcriptional abnormalities in cancers

TL;DR: In this paper, the authors investigated hierarchical topologically associating domain (TAD) structures in cancers and defined a "TAD hierarchical score (TH score)" for genes, which allowed them to assess the TAD nesting level of all genes in a simplified way.
Journal ArticleDOI

Clonal Evolution in Chronic Lymphocytic Leukemia

TL;DR: Genetic changes in a cohort of 143 CLL cases analyzed longitudinally for changes in acquired genomic copy number aberrations, acquired uniparental disomy, and somatically acquired mutations in the genes TP53, SF3B1, and NOTCH1 are described.
Journal ArticleDOI

PSRR: A Web Server for Predicting the Regulation of miRNAs Expression by Small Molecules

TL;DR: This study provides a novel web server that could effectively predict the regulation of miRNAs expression by small molecules and predicted binding affinities of oncogenic mi RNAs and small molecules bore a close resemblance to the lowest binding energy profiles using molecular docking.
Posted ContentDOI

Nuclear actin regulates inducible transcription by enhancing RNA polymerase II clustering

TL;DR: This work uncovers a novel role of nuclear actin in inducible transcriptional regulation using next-generation transcriptome sequencing and super-resolution microscopy and unveilsnuclear actin promotes the formation of transcription factory on inducable genes, acting as a general mechanism underlying the rapid response to environmental cues.
Posted ContentDOI

Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors

TL;DR: It is found that 2-hour sublethal TKI treatment elicits a transient drug-tolerant state in EGFR-mutant lung cancer cells and the importance of epigenetically regulated BCAT1-engaged metabolism reprogramming in TKI resistance in lung cancer is revealed.